Comparison of osteoclastogenesis and local invasiveness of ameloblastoma and keratocystic odontogenic tumor
- PMID: 29657523
- PMCID: PMC5883474
- DOI: 10.4103/ejd.ejd_54_17
Comparison of osteoclastogenesis and local invasiveness of ameloblastoma and keratocystic odontogenic tumor
Abstract
Objectives: The aim of this study was to compare the expression of receptor-activated nuclear factor kappa B (RANK) with its ligand (RANKL) and matrix metalloproteinase-2 (MMP2) in solid/multicystic ameloblastomas (ABs) and keratocystic odontogenic tumors (KOTs).
Materials and methods: The expression of MMP2, RANK, and RANKL molecules was evaluated in 13 ABs and 14 KOTs by immunohistochemistry. The expressions were calculated in the odontogenic epithelial cells as well as the stromal cells.
Results: Odontogenic epithelia of AB expressed MMP2, RANK, and RANKL significantly higher than that of KOTs (P < 0.05). The expression of MMP2, RANK, and RANKL was highest in plexiform subtype (79.9%, 81.08%, and 65.1%, respectively). KOTs without daughter epithelia nests expressed both MMP2 and RANK the least (56.06% and 47.5%, respectively). Stromal cells, on the other hand, expressed similar MMP2 pattern in odontogenic epithelia of both AB and KOT. RANKL was expressed weaker in the stromal cells of both lesions.
Conclusion: Invasive biological and osteolytic behaviors of both lesions were evaluated in this study. It was found to be more in AB than keratocystic odontogenic. A significant expression of MMP2, RANK, and RANKL in both KOTs associated with microcyst and plexiform type AB as well.
Keywords: Keratocystic odontogenic tumor; matrix metalloproteinase-2; odontogenic keratocysts; receptor-activated nuclear factor kappa B; receptor-activated nuclear factor kappa B ligand; solid/multicystic ameloblastoma.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP. Ameloblastoma. Am J Clin Oncol. 2007;30:645–8. - PubMed
-
- Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. Ch. 6. Lyon: IARC Press; 2005. Pathology and Genetics of Head and Neck Tumours: Odontogenic Tumours; pp. 283–328.
-
- Lacy DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclasts differentiation and activation. Cell. 1998;93:165–76. - PubMed
-
- Andrade FR, Sousa DP, Mendonça EF, Silva TA, Lara VS, Batista AC, et al. Expression of bone resorption regulators (RANK, RANKL, and OPG) in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106:548–55. - PubMed
-
- da Silva TA, Batista AC, Mendonça EF, Leles CR, Fukada S, Cunha FQ, et al. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105:333–41. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
